Ottawa, Canada

Hani Jrade


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hani Jrade: Innovating Treatments for Acute Myeloid Leukemia

Introduction

Hani Jrade, an accomplished inventor based in Ottawa, Canada, has made noteworthy contributions to the field of biomedical innovation. With a focus on developing effective treatment methods for acute myeloid leukemia (AML), his work exemplifies the potential of combining research with practical applications.

Latest Patents

Mr. Jrade holds a patent addressing the treatment of acute myeloid leukemia, specifically for cases that are refractory to induction therapy. The patent outlines methods for treating human subjects by administering an MDM2 inhibitor before or concurrently with chemotherapy. The innovation leverages a predictive mechanism based on the expression of MTF2 in cells from a hematological sample, allowing for more personalized treatment approaches. Additionally, his patent provides a comprehensive list of biomarkers useful for predicting the responsiveness of AML to MDM2/HDM2 inhibitors, including H3K27me3, CD84, and several others, which open new avenues for targeted therapies.

Career Highlights

Mr. Jrade is associated with the Ottawa Hospital Research Institute, where he utilizes his expertise to further research in cancer therapies. His contribution to developing a method that predicts and treats AML showcases his commitment to enhancing patient care and treatment outcomes.

Collaborations

Hani Jrade collaborates with notable colleagues such as William L. Stanford and Caryn Ito, working collectively to push the boundaries of research and development in the biomedical field. Their collective efforts have the potential to significantly influence therapeutic strategies in treating serious conditions like AML.

Conclusion

With a patent that innovatively addresses a pressing medical need, Hani Jrade stands out as a leading inventor in the realm of oncology. His work not only contributes to the current understanding of acute myeloid leukemia but also paves the way for future advancements in treating this challenging disease. Through collaborations and ongoing research, he continues to inspire innovation within the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…